Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
Clinical trial NCT06537843 · RECRUITING
Trial details
- NCT number
- NCT06537843
- Sponsor
- Hospital Municipal São José
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.